Abstract
Background
Progression of aortic calcification is associated with all-cause and cardiovascular mortality in hemodialysis patients. Blood calciprotein particle (CPP) levels are associated with coronary artery calcification and were reported to be inhibited when using citric acid-based bicarbonate dialysate (CD). Therefore, this study aimed to examine the effect of CD on the progression of the aortic arch calcification score (AoACS) and blood CPP levels in hemodialysis patients.
Methods
A 12-month retrospective observational study of 262 hemodialysis patients was conducted. AoACS was evaluated by calculating the number of calcifications in 16 segments of the aortic arch on chest X-ray (minimum score is 0; maximum score is 16 points). The patients were divided into the following groups according to their baseline AoACS: grade 0, AoACS = 0 points; grade 1, AoACS 1–4 points; grade 2, AoACS 5–8 points; grade 3, AoACS 9 points or higher. Patients on bisphosphonates or warfarin or with AoACS grade 3 were excluded. Progression, defined as ΔAoACS (12-month score – baseline score) > 0 points, was compared between the CD and acetic acid-based bicarbonate dialysate (AD) groups before and after adjusting the background using propensity score matching.
Results
The AoACS progression rate was significantly lower in the CD group than in the AD group (before matching: P = 0.020, after matching: P = 0.002). Multivariate logistic regression analysis showed that CD was significantly associated with AoACS progression (odds ratio 0.52, 95% confidence interval 0.29‒0.92, P = 0.025).
Conclusion
CD may slow the progression of vascular calcification in hemodialysis patients.
Graphical abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40620-022-01470-2/MediaObjects/40620_2022_1470_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40620-022-01470-2/MediaObjects/40620_2022_1470_Fig1_HTML.png)
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073–2081. https://doi.org/10.1016/S0140-6736(10)60674-5
Ogawa T, Ishida H, Matsuda N, Fujiu A, Matsuda A, Ito K, Ando Y, Nitta K (2009) Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int 13:301–306. https://doi.org/10.1111/j.1542-4758.2009.00366.x
Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K (2010) Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol 42:187–194. https://doi.org/10.1007/s11255-009-9574-5
Abdelmalek JA, Stark P, Walther CP, Ix JH, Rifkin DE (2012) Associations between coronary calcification on chest radiographs and mortality in hemodialysis patients. Am J Kidney Dis 60:990–997. https://doi.org/10.1053/j.ajkd.2012.06.018
Komatsu M, Okazaki M, Tsuchiya K, Kawaguchi H, Nitta K (2014) Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients. Kidney Blood Press Res 39:658–667. https://doi.org/10.1159/000368476
Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC, NECOSAD Study Group (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26:1662–1669. https://doi.org/10.1093/ndt/gfq582
Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21:1998–2007. https://doi.org/10.1681/ASN.2009090944
Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG (2012) Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 27:1957–1966. https://doi.org/10.1093/ndt/gfr609
Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, Renné T, Jahnen-Dechent W (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333–13341. https://doi.org/10.1074/jbc.M210868200
Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366. https://doi.org/10.1172/JCI17202
Akiyama KI, Miura Y, Hayashi H, Sakata A, Matsumura Y, Kojima M, Tsuchiya K, Nitta K, Shiizaki K, Kurosu H, Kuro-O M (2020) Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts. Kidney Int 97:702–712. https://doi.org/10.1016/j.kint.2019.10.019
Miura Y, Iwazu Y, Shiizaki K, Akimoto T, Kotani K, Kurabayashi M, Kurosu H, Kuro-O M (2018) Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Sci Rep 8:1256. https://doi.org/10.1038/s41598-018-19677-4
Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A, Naso A, Miozzo D, Giannini S, Avolio M, Foschi A, Rizzo MA, Gallieni M (2015) Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol 13:248–258. https://doi.org/10.2174/15701611113119990146
Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H (2004) Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44:680–688. https://doi.org/10.1016/S0272-6386(04)00937-0
Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y (2009) Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 75:915–928. https://doi.org/10.1038/ki.2008.700
Nakazato J, Hoshide S, Wake M, Miura Y, Kuro-O M, Kario K (2019) Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery plaque in patients with coronary artery disease: a cross sectional study. J Cardiol 74:428–435. https://doi.org/10.1016/j.jjcc.2019.04.008
Ter Meulen KJ, Dekker MJ, Pasch A, Broers NJH, van der Sande FM, van der Net JB, Konings CJAM, Gsponer IM, Bachtler MDN, Gauly A, Canaud B, Kooman JP (2019) Citric-acid dialysate improves the calcification propensity of hemodialysis patients: a multicenter prospective randomized cross- over trial. PLoS One 14:e0225824. https://doi.org/10.1371/journal.pone.0225824
Lorenz G, Mayer CC, Bachmann Q, Stryeck S, Braunisch MC, Haller B, Carbajo-Lozoya J, Schmidt A, Witthauer S, Abuzahu J, Kemmner S, Angermann S, Koneru N, Wassertheurer S, Bieber R, Heemann U, Madl T, Pasch A, Schmaderer C (2018) Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity—a preliminary study. Nephrol Dial Transplant 33:2043–2051. https://doi.org/10.1093/ndt/gfy134
Yamada S, Giachelli CM (2017) Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone 100:87–93. https://doi.org/10.1016/j.bone.2016.11.012
Villa-Bellosta R, Hernández-Martínez E, Mérida-Herrero E, González-Parra E (2019) Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification. Sci Rep 9:11374. https://doi.org/10.1038/s41598-019-47934-7
Schmitz M, Loke O, Fach B, Kalb K, Heering PJ, Meinke D, Rawer P, Galle J, Kozik-Jaromin J (2016) Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study. Nephrol Dial Transplant 31:1327–1334. https://doi.org/10.1093/ndt/gfv347
Masuda A, Hagiwara S, Tanimoto M, Kodama F, Okumura K, Nohara N, Matsumoto M, Maiguma M, Omote K, Io H, Kurusu A, Ohsawa I, Shimizu Y, Hamada C, Horikoshi S, Tomino Y (2012) Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients. Nephron Extra 2:256–268. https://doi.org/10.1159/000342258
Taki K, Takayama F, Tsuruta Y, Niwa T (2006) Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 70:218–224. https://doi.org/10.1038/sj.ki.5000330
Yamamoto Y, Sakata N, Meng J, Sakamoto M, Noma A, Maeda I, Okamoto K, Takebayashi S (2002) Possible involvement of increased glycoxidation and lipid peroxidation of elastin in atherogenesis in haemodialysis patients. Nephrol Dial Transplant 17:630–636. https://doi.org/10.1093/ndt/17.4.630
Amore A, Coppo R (2002) I Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 17:16–24. https://doi.org/10.1093/ndt/17.suppl_8.16
Pérez-García R, Chamond RR, de Sequera OP, Albalate M, Puerta Carretero M, Ortega M, Ruiz Caro MC, Alcazar Arroyo R (2017) Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate. Nefrologia 37:630–637. https://doi.org/10.1016/j.nefro.2017.03.024
Pizzarelli F, Cantaluppi V, Panichi V, Toccafondi A, Ferro G, Farruggio S, Grossini E, Dattolo PC, Miniello V, Migliori M, Grimaldi C, Casani A, Borzumati M, Cusinato S, Capitanini A, Quercia A, Filiberti O, Dani L, Hephaestus study group (2021) Citrate high volume on-line hemodiafiltration modulates serum interleukin-6 and Klotho levels: the multicenter randomized controlled study “Hephaestus.” J Nephrol 34:1701–1710. https://doi.org/10.1007/s40620-020-00943-6
Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL (2015) High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol 10:2534–2544. https://doi.org/10.1681/ASN.2014070686
Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, Matsui I, Hashimoto N, Matsumoto A, Shimada K, Takabatake Y, Takahashi A, Kaimori JY, Moriyama T, Yamamoto R, Horio M, Yamamoto K, Sugimoto K, Rakugi H, Isaka YA (2019) A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30:1073–1085. https://doi.org/10.1681/ASN.2018111150
Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A (2008) Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 40:1075–1082. https://doi.org/10.1007/s11255-008-9410-3
Acknowledgements
We are very grateful to Naganuma Toshiaki, a clinical engineering technician, for his contribution to this study.
Funding
This work was supported by JSPS KAKENHI under Grant Number JP19K17723.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design. CPP and FGF23 measurements in the blood and interpretation of the data were performed by YM and MK. Material preparation and data collection and analysis were performed by KA, NH, and TM. The first draft of the manuscript was written by KA, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Ethical approval
This study adhered to the tenets of the Declaration of Helsinki and was approved by the Medical Ethics committee of Joban Hospital, Iwaki-city, Fukushima, Japan (JHTF-2018-018, JHTF-2020-008).
Consent to participate
Consent for participation in this study was obtained on an opt-out basis from patients who had already provided written informed consent for the use of residual plasma in regular practice for research purposes.
Consent to publish
Patients provided written informed consent regarding the publication of their data and chest X-ray findings.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Akiyama, Ki., Moriyama, T., Hanafusa, N. et al. Citric acid-based bicarbonate dialysate attenuates aortic arch calcification in maintenance hemodialysis patients: a retrospective observational study. J Nephrol 36, 367–376 (2023). https://doi.org/10.1007/s40620-022-01470-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-022-01470-2